These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28508128)

  • 1. The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study.
    Ogata H; Kumasawa J; Fukuma S; Mizobuchi M; Kinugasa E; Fukagawa M; Fukuhara S; Akizawa T
    Clin Exp Nephrol; 2017 Oct; 21(5):797-806. PubMed ID: 28508128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort Study.
    Yotsueda R; Taniguchi M; Tanaka S; Eriguchi M; Fujisaki K; Torisu K; Masutani K; Hirakata H; Kitazono T; Tsuruya K
    Am J Kidney Dis; 2017 Jul; 70(1):84-92. PubMed ID: 28196648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients.
    Okute Y; Shoji T; Hayashi T; Kuwamura Y; Sonoda M; Mori K; Shioi A; Tsujimoto Y; Tabata T; Emoto M; Inaba M
    J Atheroscler Thromb; 2017 Apr; 24(4):412-421. PubMed ID: 27629255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
    Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified creatinine index and risk for cardiovascular events and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort study.
    Arase H; Yamada S; Yotsueda R; Taniguchi M; Yoshida H; Tokumoto M; Nakano T; Tsuruya K; Kitazono T
    Atherosclerosis; 2018 Aug; 275():115-123. PubMed ID: 29890446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.
    Soohoo M; Feng M; Obi Y; Streja E; Rhee CM; Lau WL; Wang J; Ravel VA; Brunelli S; Kovesdy CP; Kalantar-Zadeh K
    Am J Nephrol; 2016; 43(2):85-96. PubMed ID: 26950688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
    Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Rakugi H; Isaka Y
    Clin Exp Nephrol; 2017 Apr; 21(2):333-341. PubMed ID: 27178276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of vitamin D receptor activator, incident cardiovascular disease and death in a cohort of hemodialysis patients.
    Shoji T; Marubayashi S; Shigematsu T; Iseki K; Tsubakihara Y; ;
    Ther Apher Dial; 2015 Jun; 19(3):235-44. PubMed ID: 25530222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial dilatation and ST-T changes predict cardiovascular outcome in chronic hemodialysis patients.
    Omae K; Ogawa T; Yoshikawa M; Nitta K
    Heart Vessels; 2012 Nov; 27(6):610-7. PubMed ID: 21953505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
    Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.
    Fukagawa M; Komaba H; Onishi Y; Fukuhara S; Akizawa T; Kurokawa K;
    Am J Nephrol; 2011; 33(5):427-37. PubMed ID: 21508631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of chronic kidney disease on hospitalization, chronic dialysis, and mortality in Japanese men: a longitudinal analysis.
    Nishikawa K; Takahashi K; Yamada R; Kinaga T; Masato M; Yamamoto M
    Clin Exp Nephrol; 2017 Apr; 21(2):316-323. PubMed ID: 27339450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geriatric nutritional risk index accurately predicts cardiovascular mortality in incident hemodialysis patients.
    Takahashi H; Ito Y; Ishii H; Aoyama T; Kamoi D; Kasuga H; Yasuda K; Maruyama S; Matsuo S; Murohara T; Yuzawa Y
    J Cardiol; 2014 Jul; 64(1):32-6. PubMed ID: 24365385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
    Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
    Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan.
    Maruyama Y; Taniguchi M; Kazama JJ; Yokoyama K; Hosoya T; Yokoo T; Shigematsu T; Iseki K; Tsubakihara Y
    Nephrol Dial Transplant; 2014 Aug; 29(8):1532-8. PubMed ID: 24642419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.
    Block GA; Kilpatrick RD; Lowe KA; Wang W; Danese MD
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2132-40. PubMed ID: 24052218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study.
    Hayashi M; Abe T; Iwai M; Matsui A; Yoshida T; Sato Y; Kanno Y;
    Clin Exp Nephrol; 2016 Oct; 20(5):787-794. PubMed ID: 26627501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.
    Ishigami J; Iimori S; Kuwahara M; Sasaki S; Tsukamoto Y
    Nephrology (Carlton); 2014 Dec; 19(12):777-83. PubMed ID: 25142830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients.
    Merle E; Roth H; London GM; Jean G; Hannedouche T; Bouchet JL; Drüeke T; Fouque D; Daugas E;
    Kidney Int; 2016 Mar; 89(3):666-74. PubMed ID: 26880460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.